Previous Article | Next Article 
Applied and Environmental Microbiology, May 2009, p. 3358-3361, Vol. 75, No. 10
0099-2240/09/$08.00+0 doi:10.1128/AEM.02538-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.
Activation and Transfer of the Chromosomal Phage Resistance Mechanism AbiV in Lactococcus lactis
Jakob Haaber,1
Sylvain Moineau,2 and
Karin Hammer1*
Center for Systems Microbiology, DTU Systems Biology, Technical University of Denmark, DK-2800 Lyngby, Denmark,1
Département de Biochimie et de Microbiologie, Faculté des Sciences et de Génie, Groupe de Recherche en Écologie Buccale, Faculté de Médecine Dentaire, Félix d'Hérelle Reference Center for Bacterial Viruses, Université Laval, Québec, Canada G1V 0A62
Received 6 November 2008/
Accepted 9 March 2009

ABSTRACT
AbiV is a chromosomally encoded phage resistance mechanism that
is silent in the wild-type phage-sensitive strain
Lactococcus lactis subsp.
cremoris MG1363. Spontaneous phage-resistant mutants
of
L. lactis MG1363 were analyzed by reverse transcriptase PCR
and shown to express AbiV. This expression was related to a
reorganization in the upstream region of
abiV. Transfer of
abiV between two lactococcal strains, most likely by conjugation,
was also demonstrated. To our knowledge, this is the first report
of natural transfer of a chromosomally encoded phage resistance
mechanism.

INTRODUCTION
Industrial milk fermentation is dependent on the well-characterized
metabolic features of commercial starter cultures, which contain
strains of lactic acid bacteria (
6). However, milk fermentation
failures due to virulent phages that are infecting these specialized
bacterial cultures is a persistent problem for the dairy industry
(
6,
8,
9,
26). Decades of research have led to the discovery
of a number of natural defense systems in
Lactococcus lactis cells, including the inhibition of phage adsorption (
12,
21)
and DNA entry (
25), restriction/modification systems (
1,
12),
and abortive infection (Abi) mechanisms (
5). These antiviral
mechanisms have been used extensively in a relatively small
number of industrial strains (
7), which has favored the emergence
of phage mutants that are insensitive to the natural antiphage
barriers (
8,
12,
26). This viral evolutionary process has led
to a lasting search for new ways to protect cultures against
phage attacks. Moreover, to avoid the use of genetic engineering
technology, the dairy industry is currently depending on the
isolation of novel natural phage resistance barriers in a given
wild-type
L. lactis isolate that can be naturally transferred
into industrial starter strains.
Most known lactococcal restriction/modification and Abi systems are plasmid encoded (2, 3, 5, 10, 11, 13, 20, 29, 39), and some of them can be easily transferred from one strain to another through conjugation. This genetic transformation process is universally accepted and has been successfully utilized to create phage-resistant starter cultures (1, 6, 19, 26, 28, 30, 34). Some phage resistance mechanisms are also chromosomally encoded. However, their industrial application is limited because they cannot be transferred into the desired industrial strains without the use of genetic engineering.
Recently, we isolated a novel chromosomally encoded Abi mechanism named AbiV (17) that is active against several lactococcal phages. The abiV gene is silent in the phage-sensitive strain L. lactis subsp. cremoris MG1363, but it can be activated when a promoter is provided (17). Here, we report the isolation of natural bacteriophage-insensitive mutants (BIMs) of L. lactis MG1363 that spontaneously express AbiV. Furthermore, we demonstrate that abiV can be transferred to lactococcal strains with a protocol used for conjugation assays.

Isolation of mutants of L. lactis MB112 spontaneously expressing AbiV.
To investigate whether MG1363 could mutate spontaneously to
express AbiV, we isolated mutants that could grow in the presence
of the virulent phage sk1 (
4). Ten independent cultures of
L. lactis MB112 (fluorouracil-resistant
L. lactis MG1363,
upp)
(
24) were grown exponentially at 30°C in M17 medium (
37)
supplemented with 0.5% glucose and then mixed with the 936-like
phage sk1 at a multiplicity of infection of >1 in the presence
of 10 mM CaCl
2. The phage-infected bacterial cultures were then
incubated for 10 min at room temperature before plating and
incubation overnight at 36°C. BIMs that spontaneously gained
resistance to sk1 were observed at a frequency of 10
–8.
Fifty-six colonies were picked randomly among the 10 independent
cultures, purified, and cross-streaked (
31) against virulent
phages sk1, p2 (
27), 712 (
23), and the AbiV-insensitive mutant
p2.1 (
18). A BIM expressing AbiV is expected to be resistant
to phages sk1 and p2 but sensitive to 712 and p2.1 due to the
absence of a functional AbiV target gene (
sav) in the latter
two phages (
18). Of the 56 BIMs, one had the expected efficiency
of plaquing (EOP) (
32) values. The EOP values for this BIM (named
L. lactis JH-80) were 2
x 10
–5 for phage p2, 0.75 for
phage 712, and 0.8 for phage p2.1 (
17). These values correspond
to values obtained with
L. lactis JH-20 and JH-32 (engineered
strains expressing AbiV; see below) (
17), suggesting that the
natural BIM
L. lactis JH-80 may now be expressing AbiV.
To verify that the phage resistance phenotype was indeed caused by the production of AbiV, the transcription of abiV in L. lactis JH-80 was investigated by using reverse transcriptase PCR (RT-PCR) as described previously (17). The RT-PCR was performed on RNA isolated from L. lactis JH-80 and also on RNA from L. lactis JH-20 (L. lactis MB112 containing abiV cloned into the expression vector pLC5) (17), JH-54 (L. lactis MB112 containing pLC5 without abiV) (17), and JH-32 (L. lactis MB112 expressing abiV due to the integration of pGhost9::ISS1) (17). While the levels of abiV mRNA in L. lactis strains JH-20 and JH-32 were the highest, JH-80 also showed transcription in comparison to undetectable transcription in L. lactis JH-54 (Fig. 1A). No PCR products were obtained in control experiments (omitting the RT enzyme), indicating that the RNA preparations were free of contaminating DNA (Fig. 1B). The above data demonstrate that L. lactis BIMs that spontaneously express AbiV, thereby conferring phage resistance to the cell without artificial genetic modifications, can be isolated.
In an attempt to elucidate the mutation(s) in the BIM
L. lactis JH-80 (AbiV
+), we PCR amplified a 6,320-bp region (nucleotides
[nt] 698427 to 704747 in GenBank AM406671) that included the
upstream region of
abiV. The PCR-amplified DNA fragments of
both
L. lactis JH-80 and reference strain
L. lactis MB112 were
sequenced on both strands. The
L. lactis MB112 sequence was
identical to the
L. lactis MG1363 sequence. However, four point
mutations were found in JH-80, located between 400 bp and 700
bp upstream of
abiV but within the upstream gene
tnp981 that
codes for a putative transposase for the insertion sequence
IS
981F (Fig.
2). Analysis of the region containing the mutations
revealed 100% nucleotide identity with the 3' region (500 nt)
of a transposase (nt 705075 to 705926 in GenBank AM406671) which
shares 99% nucleotide identity with
tnp981. This transposase
is inversely oriented and located 6,671 bp upstream of
abiV (Fig.
2). The exact match of the mutated region in
tnp981 to
this transposase and the absence of large inversions in the
6-kb region upstream of
abiV strongly indicate that the mutations
were caused by recombination between the two genes.
No terminator structure could be identified between
abiV and
tnp981, leaving the possibility that promoter activity upstream
or within
tnp981 caused the increased expression of
abiV in
JH-80. We therefore determined the transcription level of
tnp981 in
L. lactis strains JH-80, JH-32, JH-20, and JH-54. We observed
faint bands in all cases, indicating that
tnp981 was transcribed
at low levels in the four strains (Fig.
1C). However, nine other
transposases that share 99% nucleotide similarity with
tnp981 exist on the genome of
L. lactis MG1363, thereby complicating
the analysis of the expression of
tnp981. Nevertheless, since
the transcription levels of
tnp981 were similar in all strains
tested, we concluded that the increased promoter activity upstream
of
tnp981 was not the cause of the elevated levels of
abiV in
L. lactis JH-80.
To test whether the observed mutations in L. lactis JH-80 were involved in abiV transcription, we performed RT-PCR (Fig. 1D and Fig. 2). The resulting data indicate that the abiV transcripts start between 727 nt and 1,079 nt upstream of the gene. Determination of the abiV 5' mRNA ends was performed by using the rapid amplification of cDNA ends (RACE) method (38). abiV mRNA ends were found at 320 nt, as well as at 583 nt, upstream of the gene. Since the abiV transcription is initiated upstream of the mutations in tnp981, the expression of abiV in L. lactis JH-80 was probably not caused by increased promoter activity. Instead, the mutations may increase the stability or some antitermination of the transcript from an existing weak promoter and hence increase AbiV expression in the BIM L. lactis JH-80. However, our data do not allow us to determine the reason for the weak induction of abiV gene expression in the mutant.

Transfer of abiV between two L. lactis strains.
Most known Abi mechanisms are plasmid encoded, though it has
been argued that this overrepresentation could be due to the
technical advantages of isolating plasmid-encoded Abi systems
(
5). As indicated above, the
abiV gene is located on the chromosome
of
L. lactis MG1363 and possibly not readily transferable to
another strain, as compared to plasmid-encoded systems. However,
conjugation of chromosomal elements, facilitated by the chromosomally
encoded sex-factor that is present in, among others,
L. lactis MG1363 (
35,
36), has been previously observed in
L. lactis (
14,
16). This genetic element permits the exchange of genetic material
between lactococcal strains by chromosomal transfer and subsequent
recombination. Therefore, we investigated whether we could take
advantage of this ability to transfer an active
abiV gene from
one strain to another.
We used the donor strain L. lactis JH-32 (AbiV+, erythromycin resistant [Ermr], and fluorouracil resistant [FUr]) and the recipient strain L. lactis MG1614, an MG1363 derivative that is resistant to rifampin (rifampicin) (Rifr) and streptomycin (Strr) (15). In L. lactis JH-32, the abiV gene is activated by the vector pGhost9::ISS1 (22) inserted immediately upstream of abiV on the bacterial chromosome. We envisioned that if pGhost9::ISS1 was successfully transferred to L. lactis MG1614 by conjugation, abiV most likely would be as well, due to their close proximity on the chromosome of L. lactis JH-32 (17). Here, as a proof of concept, we used erythromycin resistance (from pGhost9::ISS1) as a selection marker.
Briefly, donor and recipient cells were grown separately on GM17 plates, subsequently recovered with saline (0.9% NaCl), and then mixed at ratios of 1:1, 1:3, and 1:9. The mixtures were immediately plated (0.1 ml plate–1) on GM17 and incubated in anaerobic jars overnight at 36°C. This incubation temperature was selected to avoid excision of the integrated pGhost9::ISS1 in L. lactis JH-32 (17, 22). Cells were recovered from GM17 plates with saline and incubated again anaerobically (48 h at 36°C) but on GM17 plates containing erythromycin (3 µg ml–1) and rifampin (100 µg ml–1). These two selection markers were used to select for L. lactis MG1614 (rifampin resistant) transconjugants that have acquired pGhost9::ISS1 (erythromycin resistance). The lactococcal colonies that grew on GM17 plates containing erythromycin and rifampin were then tested for their sensitivity to fluorouracil (0.3 µg ml–1) and their resistance to streptomycin (200 µg ml–1) and phages. By using this phage- and streptomycin-free selection approach, we virtually eliminated the risk of isolating false positives due to spontaneous mutations causing the resistance phenotype. Transconjugants with the phenotype, Rifr, Strr, FUs, Ermr, and phage resistance, are expected to be derivatives of MG1614 (Rifr Strr) that have acquired Ermr and phage resistance from JH-32 by chromosomal transfer.
Seven putative transconjugants (Ermr Rifr) were first isolated after two days of anaerobic incubation (36°C). Five of these mutants were derived from the donor and had acquired a spontaneous Rifr resistance. One mutant was derived from the recipient, with a spontaneous Ermr mutation. However, one mutant (L. lactis JH-83) had the expected phenotype (Rifr, Strr, FUs, Ermr, and phage resistance). In fact, phage p2 had an EOP of 10–4 on L. lactis JH-83. These data strongly suggested that L. lactis JH-83 is a transconjugant of L. lactis MG1614 that has acquired an activated abiV gene by conjugation and recombination. Next, we sequenced the rpsL gene of the four strains L. lactis MB112, MG1614, JH-32, and JH-83 and found a specific K-to-R amino acid substitution in rpsL (data not shown) that is known to cause streptomycin resistance in different bacterial species (33). The same mutation was found in L. lactis MG1614 and JH-83, while L. lactis MB112 and JH-32 had the wild-type sequence. Since rpsL was identical in JH-83 and MG1614 and streptomycin was not used as a selection marker, we concluded that indeed MG1614 was the parental origin of JH-83. To our knowledge, this is the first demonstration of a natural transfer of a chromosomally encoded phage resistance mechanism.
Taken altogether, the above data indicate that the chromosomally encoded abiV can be spontaneously activated and also naturally transferred to other lactococcal strains by conjugation. This study suggests that the search for novel chromosomally encoded Abi mechanisms should be revisited and that this may open up new ways to construct naturally phage-resistant strains for large-scale industrial applications.

ACKNOWLEDGMENTS
This work was funded in part by a graduate scholarship from
the Technical University of Denmark and a grant from the Proof-of-Concept
Consortium to J.H. and a strategic grant from the Natural Sciences
and Engineering Research Council (NSERC) of Canada to S.M.

FOOTNOTES
* Corresponding author. Mailing address: Center for Systems Microbiology, DTU Systems Biology, Matematiktorvet Bldg. 301, Technical University of Denmark, DK-2800 Lyngby, Denmark. Phone: 45 45 25 24 96. Fax: 45 45 93 28 09. E-mail:
kha{at}bio.dtu.dk 
Published ahead of print on 13 March 2009. 

REFERENCES
1 - Allison, G. E., and T. R. Klaenhammer. 1998. Phage resistance mechanisms in lactic acid bacteria. Int. Dairy J. 8:207-226.[CrossRef]
2 - Bouchard, J. D., E. Dion, F. Bissonnette, and S. Moineau. 2002. Characterization of the two-component abortive phage infection mechanism AbiT from Lactococcus lactis. J. Bacteriol. 184:6325-6332.[Abstract/Free Full Text]
3 - Boucher, I., E. Emond, E. Dion, D. Montpetit, and S. Moineau. 2000. Microbiological and molecular impacts of AbiK on the lytic cycle of Lactococcus lactis phages of the 936 and P335 species. Microbiology 146:445-453.[Abstract/Free Full Text]
4 - Chandry, P. S., S. C. Moore, J. D. Boyce, B. E. Davidson, and A. J. Hillier. 1997. Analysis of the DNA sequence, gene expression, origin of replication and modular structure of the Lactococcus lactis lytic bacteriophage sk1. Mol. Microbiol. 26:49-64.[CrossRef][Medline]
5 - Chopin, M. C., A. Chopin, and E. Bidnenko. 2005. Phage abortive infection in lactococci: variations on a theme. Curr. Opin. Microbiol. 8:473-479.[CrossRef][Medline]
6 - Coffey, A., and R. P. Ross. 2002. Bacteriophage-resistance systems in dairy starter strains: molecular analysis to application. Antonie van Leeuwenhoek 82:303-321.[CrossRef][Medline]
7 - Daly, C., G. F. Fitzgerald, L. O'Connor, and R. Davis. 1998. Technology and health benefits of dairy starter cultures. Int. Dairy J. 8:195-205.[CrossRef]
8 - Daly, C., G. F. Fitzgerald, and R. Davis. 1996. Biotechnology of lactic acid bacteria with special reference to bacteriophage resistance. Antonie van Leeuwenhoek 70:99-110.[CrossRef][Medline]
9 - Deveau, H., S. J. Labrie, M. C. Chopin, and S. Moineau. 2006. Biodiversity and classification of lactococcal phages. Appl. Environ. Microbiol. 72:4338-4346.[Abstract/Free Full Text]
10 - Durmaz, E., and T. R. Klaenhammer. 2007. Abortive phage resistance mechanism AbiZ speeds the lysis clock to cause premature lysis of phage-infected Lactococcus lactis. J. Bacteriol. 189:1417-1425.[Abstract/Free Full Text]
11 - Emond, E., E. Dion, S. A. Walker, E. R. Vedamuthu, J. K. Kondo, and S. Moineau. 1998. AbiQ, an abortive infection mechanism from Lactococcus lactis. Appl. Environ. Microbiol. 64:4748-4756.[Abstract/Free Full Text]
12 - Forde, A., and G. F. Fitzgerald. 1999. Bacteriophage defence systems in lactic acid bacteria. Antonie van Leeuwenhoek 76:89-113.[CrossRef][Medline]
13 - Garvey, P., C. Hill, and G. F. Fitzgerald. 1996. The lactococcal plasmid pNP40 encodes a third bacteriophage resistance mechanism, one which affects phage DNA penetration. Appl. Environ. Microbiol. 62:676-679.[Abstract/Free Full Text]
14 - Gasson, M., J. J. Godon, C. J. Pillidge, T. J. Eaton, K. L. Jury, and C. Shearman. 1995. Characterization and exploitation of conjugation in lactococcus lactis. Int. Dairy J. 5:757-762.[CrossRef]
15 - Gasson, M. J. 1983. Plasmid complements of Streptococcus lactis NCDO 712 and other lactic streptococci after protoplast-induced curing. J. Bacteriol. 154:1-9.[Abstract/Free Full Text]
16 - Gireesh, T., B. E. Davidson, and A. J. Hillier. 1992. Conjugal transfer in Lactococcus lactis of a 68-kilobase-pair chromosomal fragment containing the structural gene for the peptide bacteriocin nisin. Appl. Environ. Microbiol. 58:1670-1676.[Abstract/Free Full Text]
17 - Haaber, J., L. C. Fortier, S. Moineau, and K. Hammer. 2008. AbiV, a novel abortive phage infection mechanism on the chromosome of Lactococcus lactis subsp. cremoris MG1363. Appl. Environ. Microbiol. 74:6528-6537.[Abstract/Free Full Text]
18 - Haaber, J., G. M. Rousseau, K. Hammer, and S. Moineau. 2009. Identification and characterization of the phage gene sav, involved in sensitivity to the lactococcal abortive infection mechanism AbiV. Appl. Environ. Microbiol. 75:2484-2494.[Abstract/Free Full Text]
19 - Harrington, A., and C. Hill. 1991. Construction of a bacteriophage-resistant derivative of Lactococcus lactis subsp. lactis 425A by using the conjugal plasmid pNP40. Appl. Environ. Microbiol. 57:3405-3409.[Abstract/Free Full Text]
20 - Hill, C., L. A. Miller, and T. R. Klaenhammer. 1990. Nucleotide sequence and distribution of the pTR2030 resistance determinant (hsp) which aborts bacteriophage infection in lactococci. Appl. Environ. Microbiol. 56:2255-2258.[Abstract/Free Full Text]
21 - Josephsen, J., and H. Neve. 2004. Bacteriophage and antiphage mechanisms of lactic acid bacteria, p. 295-350. In S. Salminen, A. von Wright, and A. Ouwehand (ed.), Lactic acid bacteria, microbiological and functional aspects. CRC Press, London, United Kingdom.
22 - Maguin, E., H. Prevost, S. D. Ehrlich, and A. Gruss. 1996. Efficient insertional mutagenesis in lactococci and other gram-positive bacteria. J. Bacteriol. 178:931-935.[Abstract/Free Full Text]
23 - Mahony, J., H. Deveau, S. McGrath, M. Ventura, C. Canchaya, S. Moineau, G. F. Fitzgerald, and D. van Sinderen. 2006. Sequence and comparative genomic analysis of lactococcal bacteriophages jj50, 712 and P008: evolutionary insights into the 936 phage species. FEMS Microbiol. Lett. 261:253-261.[CrossRef][Medline]
24 - Martinussen, J., and K. Hammer. 1994. Cloning and characterization of upp, a gene encoding uracil phosphoribosyltransferase from Lactococcus lactis. J. Bacteriol. 176:6457-6463.[Abstract/Free Full Text]
25 - McGrath, S., G. F. Fitzgerald, and D. van Sinderen. 2002. Identification and characterization of phage-resistance genes in temperate lactococcal bacteriophages. Mol. Microbiol. 43:509-520.[CrossRef][Medline]
26 - Moineau, S. 1999. Applications of phage resistance in lactic acid bacteria. Antonie van Leeuwenhoek 76:377-382.[CrossRef][Medline]
27 - Moineau, S., S. A. Walker, E. R. Vedamuthu, and P. A. Vandenbergh. 1995. Cloning and sequencing of LlaDCHI [corrected] restriction/modification genes from Lactococcus lactis and relatedness of this system to the Streptococcus pneumoniae DpnII system. Appl. Environ. Microbiol. 61:2193-2202.[Abstract/Free Full Text]
28 - Neve, H., A. Geis, and M. Teuber. 1987. Conjugation, a common plasmid transfer mechanism in lactic acid streptococci of dairy starter cultures. Syst. Appl. Microbiol. 9:151-157.
29 - O'Connor, L., A. Coffey, C. Daly, and G. F. Fitzgerald. 1996. AbiG, a genotypically novel abortive infection mechanism encoded by plasmid pCI750 of Lactococcus lactis subsp. cremoris UC653. Appl. Environ. Microbiol. 62:3075-3082.[Abstract/Free Full Text]
30 - Romero, D. A., P. Slos, C. Robert, I. Castellino, and A. Mercenier. 1987. Conjugative mobilization as an alternative vector delivery system for lactic streptococci. Appl. Environ. Microbiol. 53:2405-2413.[Abstract/Free Full Text]
31 - Ross, W., S. H. Shore, and M. M. Howe. 1986. Mutants of Escherichia coli defective for replicative transposition of bacteriophage Mu. J. Bacteriol. 167:905-919.[Abstract/Free Full Text]
32 - Sanders, M. E., and T. R. Klaenhammer. 1980. Restriction and modification in group N streptococci: effect of heat on development of modified lytic bacteriophage. Appl. Environ. Microbiol. 40:500-506.[Abstract/Free Full Text]
33 - Sreevatsan, S., X. Pan, K. E. Stockbauer, D. L. Williams, B. N. Kreiswirth, and J. M. Musser. 1996. Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities. Antimicrob. Agents Chemother. 40:1024-1026.[Abstract/Free Full Text]
34 - Steele, J., and L. McKay. 1989. Conjugal transfer of genetic material in lactococci: a review. J. Dairy Sci. 72:3388-3397.[Abstract/Free Full Text]
35 - Stentz, R., M. Gasson, and C. Shearman. 2006. The Tra domain of the lactococcal CluA surface protein is a unique domain that contributes to sex factor DNA transfer. J. Bacteriol. 188:2106-2114.[Abstract/Free Full Text]
36 - Stentz, R., K. Jury, T. Eaton, M. Parker, A. Narbad, M. Gasson, and C. Shearman. 2004. Controlled expression of CluA in Lactococcus lactis and its role in conjugation. Microbiology 150:2503-2512.[Abstract/Free Full Text]
37 - Terzaghi, B. E., and W. E. Sandine. 1975. Improved medium for lactic streptococci and their bacteriophages. Appl. Microbiol. 29:807-813.[Medline]
38 - Tillett, D., B. P. Burns, and B. A. Neilan. 2000. Optimized rapid amplification of cDNA ends (RACE) for mapping bacterial mRNA transcripts. BioTechniques 28:448-456.[Medline]
39 - Twomey, D. P., P. J. De Urraza, L. L. McKay, and D. J. O'Sullivan. 2000. Characterization of AbiR, a novel multicomponent abortive infection mechanism encoded by plasmid pKR223 of Lactococcus lactis subsp. lactis KR2. Appl. Environ. Microbiol. 66:2647-2651.[Abstract/Free Full Text]
Applied and Environmental Microbiology, May 2009, p. 3358-3361, Vol. 75, No. 10
0099-2240/09/$08.00+0 doi:10.1128/AEM.02538-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.